// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Retinol at a concentration of 0.3% restores fibrillin-rich microfibrils and modifies the epidermis in photoaged human skin in vivo in a manner similar to 1% retinol

K.T. Mellody - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Lutamin

Coagulation factor XIII-A subunit missense mutation in the pathobiology of autosomal dominant multiple dermatofibromas

C. Supsrisunjai - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Do less satisfied patients utilize more healthcare resources? A population study among U.S. adults with psoriasis

C. Read - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriasis

N/A

The association between antibiotics for acne and subsequent infection sequelae and antimicrobial resistance: A systematic review

K. Bhate - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Acne

N/A

Antihypertensives and risk of melanoma and keratinocyte carcinoma: A systematic review and meta-analysis

O.G. Cohen - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Squamous cell carcinoma

N/A

Risk of hospitalization due to infection in patients with psoriasis: A population-based cohort study using the UK Clinical Practice Research Datalink

Z.Z. Yiu - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriasis

N/A

The association between tobacco smoke exposure during childhood and adolescence and atopic dermatitis activity and severity

N.A. Al-Alusi - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Dupilumab monotherapy improves signs, symptoms and quality of life in adult and adolescent patients with erythrodermic atopic dermatitis

A. Shabbir - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

Dupilumab

The relationship between atopic dermatitis and childhood symptoms of attention deficit/hyperactivity disorder: A longitudinal cohort study

Y. Lee - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Attention deficit hyperactivity disorder

N/A

Longitudinal cohort study of the association between atopic dermatitis and depression throughout childhood

C. Kern - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Atopic Dermatitis

N/A

Evaluating world health organization essential medicines list for dermatologic disease

C.W. Rundle - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Physician assessment of alopecia areata disease severity: Results from a real-world study

R. Burge - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Differential ligand binding distinguishes therapeutic from pathologic Aryl Hydrocarbon Receptor (AhR) modulating agents: Implications for inflammatory skin disease

S. Smith - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

WBI-1001

Generation of human hair follicle organoids in vitro and ex vivo by co-culture of primary human hair matrix keratinocytes and dermal papilla fibroblasts

I. Piccini - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alkaline phosphatase

DNA dioxygenases Tet1/2/3 control hair matrix keratinocyte differentiation and hair shaft shape via regulation of hair keratin gene expression

G. Chen - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Promoting cutaneous wound healing with nutraceutical porcine type I collagen peptides

K. Mistry - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

mitomycin

A20 and its repressor DREAM expression govern susceptibility to fibrosis in systemic sclerosis

W. Wang - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

Repaglinide

Overcoming wound healing complications of radiotherapy in breast dermal fibroblasts through the influence of pre-adipocytes

L.V. Trevor - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

No detectable systemic absorption of topically applied 0.02% and 0.04% chlormethine (CL) gel in patients with mycosis-fungoides cutaneous T-cell lymphoma (MF-CTCL)

C. Querfeld - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Cutaneous T-cell lymphoma

Mechlorethamine Hydrochloride

Inhibition of sonic hedgehog signalling via MAPK activation controls chemotherapy-induced alopecia

I.S. Haslam - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved